Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-12-11

FDA Approved: DUODOTE — Supplemental Application (Meridian Medical Technologies LLC)

View source ↗

Summary

FDA approved a supplemental application for DUODOTE, a combination of atropine and pralidoxime chloride, submitted by Meridian Medical Technologies LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DUODOTE (Atropine and Pralidoxime chloride)

Snippet

SUPPL AP for DUODOTE (ATROPINE AND PRALIDOXIME CHLORIDE)